Improved diastolic function after myoblast transplantation in a model of ischemia-infarction

References

• Jessup M, Brozena S. Heart Failure. New Engl J Med 2003; 348: 2007–8
   PubMed Web of Science ®Google Scholar
• Rich MW, Nease RF. Cost-effectiveness analysis in clinical practise: The case of heart failure. Arch Intern Med 1999; 159: 1690–700
   PubMed Web of Science ®Google Scholar
• Aurigemma G, Gaasch W. Diastolic heart failure. New Engl J Med 2004; 351: 1097–105
   PubMed Web of Science ®Google Scholar
• Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003; 58: 336–50
   PubMed Web of Science ®Google Scholar
• Menasche P, Desnos M, Hagege AA. Myoblast transplantation during cardiac surgery. Eur Heart J Suppl 2006; 8(Suppl. H): H52–H56
   Web of Science ®Google Scholar
• Niagara MI, Haider H, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007; 100: 545
   PubMed Web of Science ®Google Scholar
• Murry CE, Field LJ, Menasché P. Cell-based cardiac repair. Reflections at the 10-year Point. Circulation 2005; 112: 3174–83
   PubMed Web of Science ®Google Scholar
• Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, Rozwadowska N, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 2004; 148: 531–7
   PubMed Web of Science ®Google Scholar
• Dib N, Michler RE, Pagani FD, Wright S, Kereiakes D, Lengerich R, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 2005; 112: 1748–55
   PubMed Web of Science ®Google Scholar
• Hagege A, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, Duboc D, et al. Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first Phase I cohort of patients. Circulation 2006; 114: 108–13
   Google Scholar
• Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117: 1189–200
   PubMed Web of Science ®Google Scholar
• Atkins BZ Hueman MT Meuchel JM Hutcheson KA Glower DD Taylor DA. Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res. 85:234–42.
   PubMed Web of Science ®Google Scholar
• Atkins BZ, Hueman MT, Meuchel JM, Cottman MJ, Hutcheson KA, Taylor DA. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant 1999; 18: 1173–80
   PubMed Web of Science ®Google Scholar
• Schaefer A Meyer G Fuchs M Klein G Kaplan M Wollert K et al Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: Results from the BOOST trial. Eur Heart J. 27:929–35.
   PubMed Web of Science ®Google Scholar
• Ikonen T Pätilä T Virtanen K Lommi J Lappalainen K Kankuri E et al Ligation of ameroid-stenosed coronary artery leads to reproducible myocardial infarction – A pilot study in a porcine model. J Surg Res. 2007.
   PubMedGoogle Scholar
• Schwartz H, Leiboff RH, Bren GB, Wasserman AG, Katz RJ, Varghese PJ, et al. Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol 1984; 4: 1088–93
   PubMed Web of Science ®Google Scholar
• Francois CJ., Fieno DS., Shors SM., Finn JP. Left ventricular mass: Manual and automatic segmentation of true FISP and FLASH cine MR images in dogs and pigs. Radiology 2004; 230: 389–95
   PubMed Web of Science ®Google Scholar
• Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 2005; 185: 95–102
   PubMed Web of Science ®Google Scholar
• Selvanayagam JB, Jerosch-Herold M, Porto I., Sheridan D, Cheng AS, Petersen SE, et al. Resting myocardial blood flow is impaired in hibernating myocardium: A magnetic resonance study of quantitative perfusion assessment. Circulation 2005; 112: 3289–96
   PubMed Web of Science ®Google Scholar
• Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs A, Kaul S, Laskey W, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539–42
   PubMed Web of Science ®Google Scholar
• Pätilä T, Ikonen T, Rutanen J, Ahonen A, Lommi J, Lappalainen K, et al. Vascular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia. J Heart Lung Transplant. 2006; 25: 206–13
   PubMed Web of Science ®Google Scholar
• Wisel S, Chacko SM, Kuppusamy ML, Pandian RP, Khan M, Kutala VK, et al. Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart. Am J Physiol Heart Circ Physiol. 2007; 292: H1254–H1261
   PubMed Web of Science ®Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and inproves cardiac function. Nat Med. 2001; 7: 430–6
   PubMed Web of Science ®Google Scholar
• Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004; 287: H2670–H2672
   PubMed Web of Science ®Google Scholar